Roflumilast
33 NDCs across 11 manufacturers|26 Generic,7 Brand
Roflumilast is used to treat chronic obstructive pulmonary disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 28, 2011, and the first generic was approved Jul 13, 2018. FDA's Orange Book lists 19 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $63 million on Roflumilast across 388,000 claims for 89,000 beneficiaries.
Roflumilast is available as 33 NDCs from 11 manufacturers (26 generic, 7 brand), with NADAC prices from $0.32 to $14.98 per EA — the most expensive product costs about 47× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
33
26G / 7B
Manufacturers
11
competing in market
Price Spread
$0.32 – $14.98
per EA, 30 of 33 NDCs
7d Activity
avg +1.3% WoW · of 33 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
11 manufacturers producing ROFLUMILAST(2 pricing outliers)
Frequently Asked Questions
What is Roflumilast used to treat?
Roflumilast is used to treat chronic obstructive pulmonary disease, per the National Library of Medicine's MED-RT classification.
When did Roflumilast become available as a generic?
FDA approved the first generic Roflumilast (ANDA) on Jul 13, 2018. The Orange Book currently lists 19 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Roflumilast?
In 2024, Medicare Part D spent $63 million on Roflumilast across 388,000 claims for 89,000 beneficiaries.
How many Roflumilast products are on the market?
The Roflumilast drug market contains 33 NDCs from 11 manufacturers — 26 generic and 7 brand products.
What is the price range for Roflumilast?
NADAC reference prices for Roflumilast range from $0.3160 to $14.9826 per EA — the most expensive product costs about 47× the cheapest. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Roflumilast cheaper than brand?
The average generic NADAC for Roflumilast is $0.8980 per EA, versus $14.9421 for brand-labeled products — brand versions average about 17× the generic price.
Which manufacturers make Roflumilast?
11 manufacturers list Roflumilast in NADAC. Ranked by number of NDCs, the largest are Major Pharmaceuticals (5), AstraZeneca Pharmaceuticals LP (4), Camber Pharmaceuticals Inc. (4), Zydus Pharmaceuticals (USA) Inc. (4), Novadoz Pharmaceuticals LLC (4).
How has the price of Roflumilast changed recently?
Over the past 7 days, 26 Roflumilast NDCs rose and 1 fell, with a market-wide average change of +1.3%.